Second trimester HG demands vigilance

Women who experience hyperemesis gravidarum (HG) during the second trimester have an increased risk for certain birth complications associated with placental abruption, study results show.

Researchers found that women hospitalized for HG during the second trimester had a greater risk for developing preterm pre-eclampsia, placental abruption, and having a small for gestational age (SGA) birth than women who did not develop HG in pregnancy.

"The results indicated that pregnancies with hyperemesis gravidarum in the second trimester demand an increased alertness and supervision during the pregnancy for development of any adverse outcomes with abnormal placentation," said author Marie Bolin (Uppsala University, Sweden) in a press statement.

The authors, reporting in BJOG, used data from 1,155,033 births recorded in the Swedish Medical Birth Register between 1997 and 2009. In all, 12,270 (1.1%) of women experienced HG before the third trimester, with 10,186 of these cases first occurring in the first trimester.

Compared with pregnancies without HG, women with HG in either trimester had slightly increased risks for pre-eclampsia (36%) and SGA birth (18%), and a nearly 50% increased risk for placental abruption.

However, stratified by trimester, women with second trimester HG had a 2.1-fold increased odds for preterm pre-eclampsia compared with women without HG (1.4% to 0.6% respectively).

These women also had a 3.1-fold increased odds for placental abruption (1.1 vs 0.4%), and a 1.39-fold increased odds for SGA birth (4.0 vs 2.4%).

In contrast, women presenting with HG in the first trimester did not exhibit a significantly heightened risk for these complications.

Both HG and abnormal placentation are associated with high levels of human chorionic gonadotrophin (hCG), explain the authors. They say this could explain their findings, with high levels of hCG in the second trimester secondary to abnormal placenta development.

While physicians should be alert to abnormal placentation in women with second trimester HG, further research will be needed to clarify which preventive treatments are best, the authors conclude.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Kirsty Oswald

Written by

Kirsty Oswald

Kirsty has a B.Sc. in Human Sciences from University College London. After several years working as medical copywriter, she became a medical journalist and is now freelance. Kirsty also works part-time as an editor for a London-based charity. She is particularly interested in the social and cultural aspects of science.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oswald, Kirsty. (2018, August 23). Second trimester HG demands vigilance. News-Medical. Retrieved on April 18, 2021 from https://www.news-medical.net/news/20130205/Second-trimester-HG-demands-vigilance.aspx.

  • MLA

    Oswald, Kirsty. "Second trimester HG demands vigilance". News-Medical. 18 April 2021. <https://www.news-medical.net/news/20130205/Second-trimester-HG-demands-vigilance.aspx>.

  • Chicago

    Oswald, Kirsty. "Second trimester HG demands vigilance". News-Medical. https://www.news-medical.net/news/20130205/Second-trimester-HG-demands-vigilance.aspx. (accessed April 18, 2021).

  • Harvard

    Oswald, Kirsty. 2018. Second trimester HG demands vigilance. News-Medical, viewed 18 April 2021, https://www.news-medical.net/news/20130205/Second-trimester-HG-demands-vigilance.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
COVID-19 vaccine acceptance in pregnancy